It is estimated that five million Americans suffer from moderate to severe aortic valve disease, making it the third most common type of cardiovascular disease. Aortic valve replacement, which is second leading reason for undergoing open heart surgery, is the prevailing treatment for patients with extensive aortic valve pathologies. Currently, substitute valves used to replace the disease valves are classified as either mechanical or biological, each of which carry significant disadvantages. Patients with mechanical valves are at a much higher risk for developing blood clots and therefore must remain on anticoagulants for the remainder of their lifetime; and biological valves, which are typically derived from porcine or cadeveric tissues, will deteriorate over time. The ideal replacement valve is one that presents no thrombogenicity or immunogenecity, provides normal hemodynamics, is free of blood damaging elements, offers a practical mode for implantation, is able to grow and remodel, and does not deteriorate over time.
Skip Nav Destination
ASME 2009 Summer Bioengineering Conference
June 17–21, 2009
Lake Tahoe, California, USA
Conference Sponsors:
- Bioengineering Division
ISBN:
978-0-7918-4891-3
PROCEEDINGS PAPER
Recellularization Potential of Acellular Aortic Valve Scaffolds Treated With Collagenase and Acetic Acid
Benjamin C. Weed,
Benjamin C. Weed
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
Ali Borazjani,
Ali Borazjani
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
Scott Metzler,
Scott Metzler
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
Filip To,
Filip To
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
James Warnock,
James Warnock
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
Jun Liao
Jun Liao
Mississippi State University, Mississippi State, MS
Search for other works by this author on:
Benjamin C. Weed
Mississippi State University, Mississippi State, MS
Ali Borazjani
Mississippi State University, Mississippi State, MS
Scott Metzler
Mississippi State University, Mississippi State, MS
Filip To
Mississippi State University, Mississippi State, MS
James Warnock
Mississippi State University, Mississippi State, MS
Jun Liao
Mississippi State University, Mississippi State, MS
Paper No:
SBC2009-206842, pp. 1207-1208; 2 pages
Published Online:
July 19, 2013
Citation
Weed, BC, Borazjani, A, Metzler, S, To, F, Warnock, J, & Liao, J. "Recellularization Potential of Acellular Aortic Valve Scaffolds Treated With Collagenase and Acetic Acid." Proceedings of the ASME 2009 Summer Bioengineering Conference. ASME 2009 Summer Bioengineering Conference, Parts A and B. Lake Tahoe, California, USA. June 17–21, 2009. pp. 1207-1208. ASME. https://doi.org/10.1115/SBC2009-206842
Download citation file:
6
Views
Related Proceedings Papers
Related Articles
Ventricular Assist Devices: Current State and Challenges
J. Med. Devices (December,2017)
3D CAD Based Conceptual Design of a Novel Aortic Valve Stent
J. Med. Devices (June,2009)
Related Chapters
Introduction
Mechanical Blood Trauma in Circulatory-Assist Devices
Occlusion Identification and Relief within Branched Structures
Biomedical Applications of Vibration and Acoustics in Therapy, Bioeffect and Modeling
Introduction
Modified Detrended Fluctuation Analysis (mDFA)